GSKGSK
13F holders, Q1 2025 (March 31)6holders
0new positions
0sold out
$38.74avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding GSK PLC (GSK) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Kahn Brothers Group Inc. ($31.9M), Paradigm Asset Management Co. LLC ($50K) and PARK CIRCLE Co ($31K).
- Company
- GSK PLC
- Filed as
- GLAXOSMITHKLINE PLC (Q1 2025)
- CUSIP
- 37733W105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 62,481 shares sold, net −62,481 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Kahn Brothers Group Inc. | 6.44% | Reduce -7.1% | 822,227 | $31.9M |
| Paradigm Asset Management Co. LLC | 0.01% | No change | 1,300 | $50K |
| PARK CIRCLE Co | 0.03% | No change | 800 | $31K |
| Asset Planning,Inc | 0.01% | No change | 264 | $10K |
| Byrne Asset Management LLC | 0.00% | No change | 56 | $2K |
| Huntington National Bank | 0.00% | No change | 1 | $40 |
"% of holder's portfolio" is GSK's weight in each manager's 13F, not the share of GSK PLC the manager owns.